446 related articles for article (PubMed ID: 30359303)
1. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
[TBL] [Abstract][Full Text] [Related]
2. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression.
Weickert MT; Hecker JS; Buck MC; Schreck C; Rivière J; Schiemann M; Schallmoser K; Bassermann F; Strunk D; Oostendorp RAJ; Götze KS
Sci Rep; 2021 Mar; 11(1):5944. PubMed ID: 33723276
[TBL] [Abstract][Full Text] [Related]
4. Alteration Analysis of Bone Marrow Mesenchymal Stromal Cells from De Novo Acute Myeloid Leukemia Patients at Diagnosis.
Desbourdes L; Javary J; Charbonnier T; Ishac N; Bourgeais J; Iltis A; Chomel JC; Turhan A; Guilloton F; Tarte K; Demattei MV; Ducrocq E; Rouleux-Bonnin F; Gyan E; Hérault O; Domenech J
Stem Cells Dev; 2017 May; 26(10):709-722. PubMed ID: 28394200
[TBL] [Abstract][Full Text] [Related]
5. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts.
Blau O; Baldus CD; Hofmann WK; Thiel G; Nolte F; Burmeister T; Türkmen S; Benlasfer O; Schümann E; Sindram A; Molkentin M; Mundlos S; Keilholz U; Thiel E; Blau IW
Blood; 2011 Nov; 118(20):5583-92. PubMed ID: 21948175
[TBL] [Abstract][Full Text] [Related]
7. Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes.
Diaz de la Guardia R; Lopez-Millan B; Lavoie JR; Bueno C; Castaño J; Gómez-Casares M; Vives S; Palomo L; Juan M; Delgado J; Blanco ML; Nomdedeu J; Chaparro A; Fuster JL; Anguita E; Rosu-Myles M; Menéndez P
Stem Cell Reports; 2017 Jun; 8(6):1573-1586. PubMed ID: 28528702
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
Pleyer L; Valent P; Greil R
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
[TBL] [Abstract][Full Text] [Related]
9. Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Chaudhary AK; Chaudhary S; Ghosh K; Shanmukaiah C; Nadkarni AH
Asian Pac J Cancer Prev; 2016; 17(3):1519-29. PubMed ID: 27039800
[TBL] [Abstract][Full Text] [Related]
10. Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.
Le Y; Fraineau S; Chandran P; Sabloff M; Brand M; Lavoie JR; Gagne R; Rosu-Myles M; Yauk CL; Richardson RB; Allan DS
Stem Cell Rev Rep; 2016 Apr; 12(2):235-44. PubMed ID: 26649729
[TBL] [Abstract][Full Text] [Related]
11. Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.
Borella G; Da Ros A; Borile G; Porcù E; Tregnago C; Benetton M; Marchetti A; Bisio V; Montini B; Michielotto B; Cani A; Leszl A; Campodoni E; Sandri M; Montesi M; Bresolin S; Cairo S; Buldini B; Locatelli F; Pigazzi M
Blood; 2021 Aug; 138(7):557-570. PubMed ID: 34010415
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of SPINT2/HAI-2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion.
Roversi FM; Cury NM; Lopes MR; Ferro KP; Machado-Neto JA; Alvarez MC; Dos Santos GP; Giardini Rosa R; Longhini AL; Duarte ADSS; Pericole FV; Favaro P; Yunes JA; Saad STO
J Cell Mol Med; 2019 Feb; 23(2):1562-1571. PubMed ID: 30484958
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.
Huang JC; Basu SK; Zhao X; Chien S; Fang M; Oehler VG; Appelbaum FR; Becker PS
Blood Cancer J; 2015 Apr; 5(4):e302. PubMed ID: 25860293
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors.
Chandran P; Le Y; Li Y; Sabloff M; Mehic J; Rosu-Myles M; Allan DS
Leuk Res; 2015 Apr; 39(4):486-93. PubMed ID: 25703353
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal cells shape the MDS microenvironment by inducing suppressive monocytes that dampen NK cell function.
Sarhan D; Wang J; Sunil Arvindam U; Hallstrom C; Verneris MR; Grzywacz B; Warlick E; Blazar BR; Miller JS
JCI Insight; 2020 Mar; 5(5):. PubMed ID: 32045384
[TBL] [Abstract][Full Text] [Related]
18. Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development.
Sabbah R; Saadi S; Shahar-Gabay T; Gerassy S; Yehudai-Resheff S; Zuckerman T
Cell Commun Signal; 2023 Oct; 21(1):277. PubMed ID: 37817179
[TBL] [Abstract][Full Text] [Related]
19. Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway.
Pavlaki K; Pontikoglou CG; Demetriadou A; Batsali AK; Damianaki A; Simantirakis E; Kontakis M; Galanopoulos A; Kotsianidis I; Kastrinaki MC; Papadaki HA
Stem Cells Dev; 2014 Jul; 23(14):1568-81. PubMed ID: 24617415
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support.
Azadniv M; Myers JR; McMurray HR; Guo N; Rock P; Coppage ML; Ashton J; Becker MW; Calvi LM; Liesveld JL
Leukemia; 2020 Feb; 34(2):391-403. PubMed ID: 31492897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
